期刊文献+

CD基因表达诱导结肠癌细胞的凋亡作用 被引量:1

Induction of apoptosis in colon cancer cells by CD gene expression
下载PDF
导出
摘要 目的:研究胞嘧啶脱氨酶(cytosinedeaminase,CD)基因表达是否具有诱导结肠癌细胞凋亡的作用。方法:用不同浓度的5氟胞嘧啶(5flurocytosine,5FC)加至CD基因阳性人结肠癌细胞株SW1116培养,MTT法检测5FC药物对结肠癌细胞生长抑制作用。AnnexinV/PI法分析细胞凋亡率,用透射电镜观察细胞结构改变。结果:与未导入基因的SW1116细胞相比,CD基因阳性细胞对5FC的敏感性明显增加,50%细胞生长抑制率(IC50)浓度由SW1116细胞的16000μmol/L降低到SWCD2的66μmol/L。CD基因导入细胞能够增加5FC诱导的细胞凋亡率。SW1116细胞凋亡率:未加药为2.52%,加药24h为4.61%,48h为2.25%,72h为8.41%;而SWCD2的凋亡率:未加药为4.81%,加药后24h为4.73%,48h为20.78%,72h为32.92%,细胞凋亡率的增加与给药时间成正比。电镜下可见明显的凋亡细胞形态特征。结论:CD基因表达对人结肠癌细胞生长的抑制作用涉及肿瘤细胞凋亡机制。 OBJECTIVE: To investigate the induction of apoptosis in colon cancer cells by CD gene expression. METHODS: Colon cancer cell line SW1116 transfected with CD gene was cultured with 5-FC. The cytotoxicity of 5-FC was assayed with MTT, the apoptosis rates was measured by Annextin V/PI labeling through FCM and the structure of cell was observed by electron microscopy. RESULTS: The transgene cells SWCD2 increased the sensitivity to the nontoxic prodrug 5-FC, decreasing the IC50 for 5-FC from 16 000 μmol/L for parental SW1116 cell to 66 μmol/L for SWCD2 cell. The apoptosis rates of SWCD2 was 4. 81% in control cells, 4.73% exposured to 5-FC after 24 h, 20. 78% after 48 h and 32.92% after 72 h. The increase of apoptosis rate was dependent on the time exposured to 5-FC. The characteristic of apoptosis was observed in SWCD2 cells after exposured to 5-FC. CONCLUSION: The growth inhibition of colon cancer cell is involved in apoptosis mechanism by CD gene expression.
出处 《中华肿瘤防治杂志》 CAS 2006年第1期3-6,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金资助项目(30070236)
关键词 结肠肿瘤 胞嘧啶脱氨酸 氟胞嘧啶/药理学 细胞凋亡 比色法 colonic neoplasms cytosine deaminase flucytosine/pharmacology apoptosis colorimetry
  • 相关文献

参考文献8

  • 1Cote R J,Esrig D,Groshen S,et al.p53 and treatment of bladder cancer[J].Nature,1997,385(9):123-125.
  • 2Mullen C A,Kilstrup M,Blaese R M,et al.Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine:a negative selection system[J].Proc Natl Acad Sci USA,1992,89(1):33-37.
  • 3黄建华,王瑶,李崇辉,钟大光,吕海燕.胞嘧啶脱氨酶基因联合5-Fc治疗结肠癌的实验研究[J].中华肿瘤杂志,2005,27(1):6-8. 被引量:4
  • 4Yin L,Fu S,Wang X,et al,Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit[J].Clin Med J,2001,114(9):972-975.
  • 5Miller C R,Williams C R,Buchsbaum D J,et al.Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas[J].Cancer Res,2002,62 (3):773-780.
  • 6Adachi Y,Tamiya T,Ichikawa T,et al.Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine[J].Hum Gene Ther,2000,11 (1):77-89.
  • 7Freeman S M,Ramesh R,Marrogi A J.Immune system in suicide-gene therapy[J].Lancet,1997,349(9044):2-3.
  • 8Corban-Wilhelm H,Ehemann V,Becker G,et al.Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy[J].Cancer Gene Ther,2004,11 (3):208-214.

二级参考文献7

  • 1Mullen CA, Kilstrup M, Blaese RM. Trmlsier of the bacterial gene for cytosine deaminase to nkanunalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.Proc Nail Acad Sci USA,1992, 89: 33-37.
  • 2Moolten FL. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther, 1994, 1 : 279-287.
  • 3Kotani H, Newton PB 3rd, Zhang S, et al. Improved methods of retroviral vector transduction and production for gene therapy.Hum Gene Ther, 1994. 5: 19-28.
  • 4Yin L, Fu S, Wang X, el al. Sensitization of prostate cancer cell linesto 5-fluorocytosine indueed by adenoviral carrying a CD transcription unit. Chin Med J, 2001, 114: 972-975.
  • 5Miller-CR. Williams CR. Buehsbaum DJ, et al. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluoroeytosine gene therapy is effective for experimental human glioblastomas. Cancer Res.2002. 62: 773-780.
  • 6Adachi Y, Tamiya T, Ichikawa T, et al. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene mad uracil phosphoribosyltransferase gene with 5-fluorocytosine.Hum Gene Ther, 2000, 11 : 77-89.
  • 7Corban-Wilhelm H, Hull WE, Becker G, el al. Cytosine deaminase and thymidine kinase gene therapy in a dunning rat prostate tumour model:absence of bystander effects and characterisation of 5-fluorcytosine metabolism with J9F-NMR spectroscopy. Gene Ther, 2002, 9: 1564-1575.

共引文献3

同被引文献10

  • 1陈玉霞,李宗斌,刁飞,王燕,卢建.地塞米松抑制人卵巢癌细胞HO-8910增殖的分子机制:RhoB信号通路的作用[J].中华医学杂志,2006,86(20):1400-1404. 被引量:13
  • 2Oakley R H,Sar M,Cidlowski J A.The human glucocorticoid receptor βisoform.Expression,biochemical properties,and putative function[J].J Biol Chem,1996,71(16):9550-9559.
  • 3Gaynon P S,Carrel A L.Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia[J].Adv Exp Med Biol,1999,457:593-605.
  • 4Reichardt H M,Tuckermann J P,Bauer A,et al.Molecular genetic dissection of glucocorticoid receptor function in vivo[J].Z Rheumatol,2000,59(Suppl 2):Ⅱ/1-5.
  • 5Goke M N,Schneider M,Beil W,et al.Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium[J].Regul Pept,2002,105(3):203-214.
  • 6Alford T C,Do H M,Geelhoed G W,et al.Steroid hormone receptors in human colon cancers[J].Cancer,1979,43:980-984.
  • 7Theocharis S,Koubaklic G,Margeli A,et al.Glucocorticoid receptor (GB) immunohistochemical expbession is correlated with cell cycle-related molecules in human colon cancer[J].Digestive Diseases and Sciences,2003,48(9):1745-1750.
  • 8Lu Y S,Yeh P Y,Chuang S E,et al.Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa[J].J Endocrinol,2006,188(2):311-319.
  • 9Wang H,Li M,Rinehart J J,et al.Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts:in vivo activity,pharmacokinetics,and clinical implications for cancer chemotherapy[J].Clin Cancer Res,2004,10(5):1633-1644.
  • 10Park J H,Oh E J,Choi Y H,et al.Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells[J].Int J Oncol,2001,18(5):997-1002.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部